跳至主要内容
临床试验/NCT06954337
NCT06954337招募中不适用

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Memorial Sloan Kettering Cancer Center14 个研究点 分布在 1 个国家目标入组 1,750 人开始时间: 2025年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
1,750
试验地点
14
主要终点
Proportion of routine face to face medical oncology related visits out of total medical oncology related visits

研究概览

简要总结

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.

排除标准

  • •Patient is enrolled on a therapeutic clinical trial.
  • •Patients whose primary language is not currently supported by Epic.

研究组 & 干预措施

Usual practice pattern (UPP)

Active Comparator

Usual practice pattern (UPP) of patient's medical oncologist

干预措施: Usual practice pattern (UPP) (Other)

Usual practice pattern (UPP)

Active Comparator

Usual practice pattern (UPP) of patient's medical oncologist

干预措施: Experimental: Enhanced Telehealth (ET) (Other)

Enhanced Telehealth (ET)

Experimental

Enhanced Telehealth (ET) practice pattern of patient's medical oncologist

干预措施: Usual practice pattern (UPP) (Other)

Enhanced Telehealth (ET)

Experimental

Enhanced Telehealth (ET) practice pattern of patient's medical oncologist

干预措施: Experimental: Enhanced Telehealth (ET) (Other)

结局指标

主要结局

Proportion of routine face to face medical oncology related visits out of total medical oncology related visits

时间窗: 12 months

all patients who meet eligibility criteria and have completed at least 2 medical oncology visits during the 12 month follow up period will be included for endpoint evaluability during analyses

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验